ST PETERSBURG, 29 March (BelTA) – It is necessary to secure a consistent decrease in the import of pharmaceutical goods. Prime Minister of Belarus Roman Golovchenko made the statement at a session of the Belarus-St Petersburg Business Cooperation Council, BelTA has learned.
Roman Golovchenko drew attention to the matter of manufacturing cooperation. Two agreements had been prepared for signing ahead of the session. One is an agreement on cooperation between OAO Mogilevliftmash and the St Petersburg Housing Committee and provides for stabilizing the joint production of lifts. The other one deals with strategic cooperation between the Belarusian Healthcare Ministry and AO BIOCAD. “We just have to support each other and joint projects. It is the key thing in our work,” the prime minister noted.
Roman Golovchenko stressed that it is hard to overestimate the significance of interaction in the pharmaceutical industry. “The Belarusian side will provide the necessary assistance with the realization of the joint project involving ZAO BIOCAD. We will support any initiatives to explore new manufacturing sites, to jointly develop pharmaceutical products and expand the choice of manufactured products,” he stated.
“It is necessary to secure a consistent decrease in the import of pharmaceutical goods. Certainly, the matter of quality of manufactured goods comes to the forefront,” the prime minister stated.
He also said he hopes that lift production in St Petersburg will be preserved and will continue. “We cannot lose it by switching to some purely market-based regulatory mechanisms. In my opinion, time is different now. We will continue supporting this manufacturing project by all means, primarily with technologies. An important advantage of making the lifts together is minimal risks with regard to the availability of components and the availability of a well-developed aftersales network. Let alone jobs and prospects of production expansion,” Roman Golovchenko stressed.